DEA Adds Benzimidazole-Opioids to Schedule I Drug List
The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids etodesnitazene, n-pyrrolidino etonitazene and protonitazene in Schedule I of the Controlled Substances Act, it said in a final order released April 10. The substances had already been temporarily listed in…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
Schedule I since 2022 (see 2204110029). The final order is set to take effect April 11.